amg 510, a novel krasg12c inhibitor, evaluated in nsclc -- r. govindan
Published 5 years ago • 941 plays • Length 6:53Download video MP4
Download video MP3
Similar videos
-
3:55
govindan discusses the phase i results of amg 510 evaluated in nsclc
-
7:51
kras g12c inhibition in advanced nsclc: amg 510
-
4:09
kras g12c inhibition in advanced nsclc: amg 510
-
3:26
amg 510: a novel molecule targeting kras g12c mutatant solid tumours
-
5:34
researcher comment: amg 510 for kras mutation-positive nsclc | ramaswamy govindan
-
1:28:28
alk 101 part 1: i've just been diagnosed with alk positive lung cancer
-
10:42
gene set analysis of gwas with magma in omicsbox
-
1:52
why does god allow cancer? ...in 90 seconds!
-
4:20
sotorasib,fda,lumakras amgen 510,non-small cell lung cancer
-
3:46
david s. hong, md, regarding the phase i clinical trial investigating sotorasib (amg 510)
-
2:43
rezilient1: zipalertinib, a novel egfr tki, in nsclc with ex20ins mutations
-
3:41
amg 510 kras inhibitor trial results – ‘a good start’ | colin lindsay
-
1:05
marwan fakih, md, considers implications from the amg 510 trial
-
1:08
dr. fakih on the safety profile of amg 510 in kras g12c-mutated crc
-
1:16
ibi351, a novel kras g12c inhibitor, in nsclc
-
1:37
expert discusses kras g12c inhibitors for patients with nsclc
-
2:38
key lung cancer updates: kras(g12c) inhibitors and adcs
-
0:31
mechanism of action of the novel krasg12c inhibitor gdc-6036
-
11:17
codebreak 100/101 first report of safety and efficacy of sotorasib pembrolizumab or atezolizum...
-
10:34
the potential of kras inhibitors for non-small-cell lung cancer
-
5:29
development of kras g12c-targeted therapy in nsclc
-
3:57
novel kinase inhibitor promising in nsclc